Skip to Content
Merck
CN

15102

Bismuth(III) gallate basic hydrate

≥98.0% (calc. on dry substance, KT), solid

Synonym(s):

2,7-Dihydroxy-1,3,2-benzodioxabismole-5-carboxylic acid, Bismuth subgallate, Dermatol

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C7H5BiO6 · xH2O
CAS Number:
99-26-3
Molecular Weight:
394.09 (anhydrous basis)
NACRES:
NA.22
PubChem Substance ID:
57647308
UNSPSC Code:
12161600
EC Number:
202-742-2
MDL number:
MFCD20441998

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Bismuth(III) gallate basic hydrate, ≥98.0% (calc. on dry substance, KT)

InChI key

VJXPXOVBMBKEHX-UHFFFAOYSA-K

InChI

1S/C7H6O5.Bi.2H2O/c8-4-1-3(7(11)12)2-5(9)6(4)10;;;/h1-2,8-10H,(H,11,12);;2*1H2/q;+3;;/p-3

SMILES string

O.O[Bi]1Oc2cc(cc(O)c2O1)C(O)=O

assay

≥98.0% (calc. on dry substance, KT)

form

solid

reaction suitability

core: bismuth, reagent type: catalyst

impurities

~10% water

Quality Level

100

Related Categories

Application

Investigations of:
  • Pharmacological activity, specifically NO and PGE2 production by macrophages
  • Treatment of Helicobacter pylori infections

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCM0946
BCCH7999
BCBV8316
BCBJ2902V
454326/1

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Sung Hyun Kim et al.
Quintessence international (Berlin, Germany : 1985), 41(8), 645-649 (2010-07-27)
To present bismuth subgallate as a simplified and efficient method for promoting hemostasis at palatal donor sites, as evaluated by measuring hemostasis time and delayed bleeding. Ten patients received the bismuth subgallate paste as a topical hemostatic agent, while another
H Leonhardt et al.
Medizinische Klinik (Munich, Germany : 1983), 86(4), 194-197 (1991-04-15)
In a cross-over study in ten healthy volunteers the effect of food on the absorption of bismuth following a single oral dose of 1200 mg (= 12 Bismofalk tablets) was evaluated by measuring its serum levels (0 to 24 h)
V Callanan et al.
The Journal of laryngology and otology, 109(3), 206-208 (1995-03-01)
The aims of this study were to demonstrate the effect of bismuth subgallate and adrenaline paste application to the tonsillar fossae on operating time and peroperative blood loss during tonsillectomy. Ninety-eight patients were included in a prospective randomized trial. Bismuth
O D Ratnoff et al.
Proceedings of the National Academy of Sciences of the United States of America, 88(23), 10740-10743 (1991-12-01)
The supernatant fluid (conditioned medium) of cultured human vascular endothelial cells inhibits activation of Hageman factor (factor XII), whether by ellagic acid, bovine brain sulfatides, or bismuth subgallate; inhibition appears to be a property of one or more proteins in
[Comment on the contribution by J. Strutz. Bismuth gallate in wound management].
B Greusing
HNO, 44(8), 426-426 (1996-08-01)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service